King George VI and Lung Cancer: A Diagnosis Kept Quiet in a Different Era

What the public was told, and what it was not

The official royal biography records the ending without medical detail. "The King failed to recover from a lung operation, and died in his sleep on 6 February 1952." He was 56, and he died at Sandringham.

That operation took place on September 23, 1951. Yahoo News UK, reviewing the events later, reported that the King's cancerous left lung was removed, and that the public was told only that part of his lung had been taken out because of "structural changes." He was a heavy smoker.

Withholding the word "cancer" from patients and the public was ordinary medical practice at the time. It is not ordinary now, and that shift is one of the largest changes in medicine since the 1950s.

This article does not speculate about anything beyond those reported facts. What follows is the disease, and how differently it is handled today.

Smoking and lung cancer, in current numbers

When George VI was operated on, the statistical link between cigarettes and lung cancer was newly published and not yet settled in the public mind. It is settled now.

The Centers for Disease Control and Prevention states that cigarette smoking or secondhand smoke exposure causes nearly 9 out of 10 lung cancer deaths, and that people who smoke raise their risk of developing lung cancer by about 25 times compared with people who do not. Cigarette smoke contains more than 7,000 chemicals, at least 69 of which can cause cancer.

CDC also attributes more than 480,000 deaths a year in the United States to cigarette smoking and secondhand smoke exposure, across all the diseases involved.

Quitting changes the arithmetic. CDC reports that quitting lowers the risk of 12 different cancers, and that 10 to 15 years after quitting, the added risk of lung cancer drops by half. It adds that research suggests people who already have cancer can reduce their risk of death by quitting.

What lung cancer is

NCI divides lung cancer into two families. Non-small cell lung cancer is the larger group, and NCI breaks it down into adenocarcinoma at roughly 40 percent of cases, squamous cell carcinoma at about 25 percent, and large cell carcinoma at about 10 percent. Small cell lung cancer accounts for about 15 percent of cancers arising in the airways, grows faster, and is treated differently.

NCI is firm that an experienced lung cancer pathologist must review the tissue, because separating the two changes everything that follows.

Symptoms

NCI lists these signs, while noting that lung cancer is sometimes found by accident on a scan ordered for another reason:

• Chest discomfort or pain.
• A cough that does not go away or gets worse over time.
• Trouble breathing, or wheezing.
• Blood in sputum, the mucus coughed up from the lungs.
• Hoarseness, or trouble swallowing.
• Loss of appetite, unexplained weight loss, and fatigue.
• Swelling in the face or in the veins of the neck.

When to get checked

Britain's NHS sets the threshold for the commonest symptom: see a doctor about a cough that has not gone away after three weeks, or a long-standing cough that has changed.

Also book an appointment for:

• Coughing up blood, even once, in any amount.
• Breathlessness on something you managed comfortably six months ago.
• Chest, shoulder, or back pain that persists without an injury.
• Hoarseness lasting more than three weeks with no cold behind it.
• Repeated chest infections, or unintended weight loss.
• New swelling of the face or neck veins, which needs urgent assessment.

Screening exists for a defined group. The US Preventive Services Task Force recommends annual low-dose CT for adults aged 50 to 80 who have a 20 pack-year smoking history and who currently smoke or quit within the past 15 years. Twenty pack-years is roughly a pack a day for 20 years. Screening ends after 15 smoke-free years, or when other health problems would rule out surgery.

The evidence comes from the National Lung Screening Trial, which found 20 percent fewer lung cancer deaths with low-dose CT than with chest x-ray, and calculated that 320 people needed screening to prevent one death. The harms are real, with false positives in roughly 23 percent of screening rounds.

Diagnosis, then and now

In 1951, a chest x-ray and a surgeon's judgment were most of what existed. The staging tools now considered routine did not.

Today NCI describes a chest x-ray and contrast-enhanced CT as the starting point, followed by tissue sampling. That may come from fine-needle aspiration, bronchoscopy, thoracoscopy, thoracentesis, or mediastinoscopy, depending on where the abnormality sits.

Staging then determines how far disease has traveled, using PET scans, brain MRI, and bone scans. Pulmonary function tests measure how much lung reserve a person has, which is what decides whether an operation is survivable and what kind is possible.

Surgery has become smaller

George VI had a pneumonectomy, meaning an entire lung was removed. NCI still lists that operation, but it also lists lobectomy, which removes only the affected lobe. A lung has five lobes, three on the right and two on the left, so a lobectomy leaves far more breathing capacity behind.

For some tumors, no incision is needed at all. Stereotactic body radiation therapy delivers precisely aimed high-dose radiation to a small target, and NCI lists it among the standard options.

Beyond surgery, treatment now depends on the tumor's genetics. NCI lists testing for EGFR, ALK, BRAF, ROS1, RET, NTRK, MET, KRAS, and HER2. ALK fusions appear in 3 to 7 percent of unselected cases, and EGFR changes are most common in adenocarcinomas in people who never smoked. Where a match exists, a targeted drug may be used. Immunotherapy and chemotherapy complete the picture.

What the numbers show

For 2026, the American Cancer Society projects 229,410 new lung and bronchus cancers and 124,990 deaths in the United States. That is 10.8 percent of new cancer diagnoses and 20.0 percent of cancer deaths.

Among people diagnosed from 2016 through 2022, five-year relative survival is 65.5 percent for localized disease, 38.2 percent for regional spread, and 10.5 percent for distant disease. Slightly more than half of cases, 51 percent, are already distant when found.

These figures come from large groups diagnosed in recent years, and they describe populations rather than people. They cannot forecast an individual outcome. What they do show is how much has changed since a king's family was told about structural changes in a lung.

Sources

• https://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq
• https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq
• https://www.cancer.gov/types/lung/hp/small-cell-lung-treatment-pdq
• https://www.cancer.gov/types/lung/hp/lung-screening-pdq
• https://seer.cancer.gov/statfacts/html/lungb.html
• https://www.cdc.gov/tobacco/about/cigarettes-and-cancer.html
• https://www.cdc.gov/tobacco/about/index.html
• https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening
• https://www.nhs.uk/conditions/lung-cancer/symptoms/
• https://www.royal.uk/george-vi
• https://uk.news.yahoo.com/on-this-day--king-george-vi-has-operation-for-fatal-lung-cancer-152303577.html